Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677514
What this trial is testing

A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd. 156
Large-scale testing (Phase 3)Looking for participantsNCT06332534
What this trial is testing

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Not applicableStudy completedNCT01289366
What this trial is testing

Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)

Who this might be right for
Crohn´s DiseaseUlcerative Colitis
University of Erlangen-Nürnberg Medical School 40
Testing effectiveness (Phase 2)UnknownNCT04713631
What this trial is testing

Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

Who this might be right for
Crohn's Disease
Sanjay Gandhi Postgraduate Institute of Medical Sciences 40
Large-scale testing (Phase 3)Study completedNCT02499783
What this trial is testing

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 205
Testing effectiveness (Phase 2)Study completedNCT00573469
What this trial is testing

Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
AstraZeneca 75
Testing effectiveness (Phase 2)Study completedNCT01190410
What this trial is testing

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

Who this might be right for
Crohn's Disease
UCB Pharma 16
Not applicableNo Longer AvailableNCT03362736
What this trial is testing

An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC
Not applicableStudy completedNCT00496548
What this trial is testing

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

Who this might be right for
Crohn's Disease
Vanderbilt University Medical Center 159
Testing effectiveness (Phase 2)Study completedNCT02877134
What this trial is testing

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 388
Large-scale testing (Phase 3)Study completedNCT00297648
What this trial is testing

Mucosal Healing Study in Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
UCB Pharma 89
Large-scale testing (Phase 3)Study completedNCT01369342
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Who this might be right for
Crohn's DiseaseInflammatory Bowel DiseaseIBD+1 more
Janssen Research & Development, LLC 640
Testing effectiveness (Phase 2)Study completedNCT02378688
What this trial is testing

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 78
Large-scale testing (Phase 3)Study completedNCT02096861
What this trial is testing

Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Celltrion 220
Large-scale testing (Phase 3)Study completedNCT03464136
What this trial is testing

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

Who this might be right for
Crohn Disease
Janssen Scientific Affairs, LLC 386
Not applicableNot Yet RecruitingNCT07356232
What this trial is testing

Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease, Active
University of Pennsylvania 80
Testing effectiveness (Phase 2)Ended earlyNCT03850509
What this trial is testing

Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation

Who this might be right for
Crohn's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 3
Post-approval studies (Phase 4)Looking for participantsNCT05928039
What this trial is testing

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

Who this might be right for
Crohn Disease
University of Calgary 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242471
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 703
Large-scale testing (Phase 3)Looking for participantsNCT05923073
What this trial is testing

Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 120
Next Page